reference/24959391

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24959391

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	701
issn	1432-1440 0946-2716
issueIdentifier	6
pageRange	691-701
publicationName	Journal of molecular medicine (Berlin, Germany)
startingPage	691
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e772875248627f4e8719220ca2ea764f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d4faf2fc1e78a131d73ea66f39089804 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Zhang L, Zhang Q, Li L, Wang Z, Ying J, Fan Y, He Q, LV T, Han W, Li J, Yang Y, Xu B, Wang L, Liu Q, Sun Y, Guo Y, Tao Q, Jin J. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer. Journal of Molecular Medicine. 2015 Feb 05;93(6):691–701. doi: 10.1007/s00109-015-1255-5.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0292-5889 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce7b140cf20ae0ecc1bb014dc2164a4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2539173d47b7297a07f6a8972dd03160 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f272a6b6555daab1546319a252d541d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d507c0bce5a9c5df02b714f6f5ab340d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9ccf365ebf470e928c8d838b77d2f7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19b339dd9108dabacdef90405f26a978 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acb22515650a7ce18be41e9aeeb621fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_125b3d98a747d4b59ab13cdcbd14ccb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c59be90da1d45c41dfd98e7e3939309f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a35bfc21fbdbc771bbc5d75409d00bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db863181c7a8e4193662d18170baadd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8afb4626d454e0c5db375b8f8d708e39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5383-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a83b728e9bd4dc6d1832c97ac45a724 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0359aa8cf5f2336dc5d26a25b52c8e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31fbda11a4de5daaa0636ff4c7be9ca2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b49ced1475773f2060b1a5aed4807e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70ff20fdb3f567eab0ace6931240543e
date	2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/25648635 https://doi.org/10.1007/s00109-015-1255-5
isPartOf	https://portal.issn.org/resource/ISSN/0946-2716 https://portal.issn.org/resource/ISSN/1432-1440 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8748
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0374857 http://id.nlm.nih.gov/mesh/M0304943 http://id.nlm.nih.gov/mesh/M0024955
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8982 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a9979fef8f660c8351b0d53835536330

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9940

Total number of triples: 57.